Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Investors Business Daily
Investors Business Daily
Business
INVESTOR'S BUSINESS DAILY

Stocks Showing Improving Market Leadership: Nutanix Cl A Earns 81 RS Rating

On Wednesday, Nutanix Cl A received a positive adjustment to its Relative Strength (RS) Rating, from 78 to 81.

IBD's unique rating identifies market leadership with a 1 (worst) to 99 (best) score. The rating shows how a stock's price behavior over the trailing 52 weeks stacks up against all the other stocks in our database.

Decades of market research reveals that the top-performing stocks often have an 80 or better RS Rating in the early stages of their moves.

Risk Management In The Stock Market: How Much Money To Invest Now

Nutanix Cl A is not currently near a potential buying area. See if the stock goes on to build a base that could spark a new run.

Nutanix Cl A saw both earnings and sales growth rise last quarter. Earnings-per-share increased from 13% to 45%. Revenue rose from 11% to 16%.

The company holds the No. 49 rank among its peers in the Computer Software-Enterprise industry group. Datadog, Enfusion and Klaviyo are among the top 5 highly rated stocks within the group.

RELATED:

Which Stocks Are Showing Improved Price Performance?

Why Should You Use IBD's Relative Strength Rating?

How Relative Strength Line Can Help You Judge A Stock

Ready To Grow Your Investing Skills? Join An IBD Meetup Group!

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.